Works matching AU Davies, Melanie J.
Results: 301
An Investigation into the Relationship Between Sleep-Disordered Breathing, the Metabolic Syndrome, Cardiovascular Risk Profiles, and Inflammation Between South Asians and Caucasians Residing in the United Kingdom.
- Published in:
- Metabolic Syndrome & Related Disorders, 2012, v. 10, n. 2, p. 152, doi. 10.1089/met.2011.0073
- By:
- Publication type:
- Article
Uptake of self-management education programmes for people with type 2 diabetes in primary care through the embedding package: a cluster randomised control trial and ethnographic study.
- Published in:
- BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02372-x
- By:
- Publication type:
- Article
Increasing uptake of self-management education programmes for type 2 diabetes in primary care: the Embedding research programme including an RCT.
- Published in:
- Programme Grants for Applied Research (PGfAR), 2025, v. 13, n. 2, p. 1, doi. 10.3310/KWYF5914
- By:
- Publication type:
- Article
Semaglutide for the treatment of overweight and obesity: A review.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 18, doi. 10.1111/dom.14863
- By:
- Publication type:
- Article
Non‐inferiority and clinical superiority of glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors: Systematic analysis of cardiorenal outcome trials in type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1598, doi. 10.1111/dom.14735
- By:
- Publication type:
- Article
The effects of empagliflozin, dietary energy restriction, or both on appetite‐regulatory gut peptides in individuals with type 2 diabetes and overweight or obesity: The SEESAW randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1509, doi. 10.1111/dom.14721
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes of initial combination therapy with glucose‐lowering agents versus a stepwise approach in newly diagnosed or treatment‐naïve type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1469, doi. 10.1111/dom.14715
- By:
- Publication type:
- Article
Energy intake and weight during the COVID‐19 lockdown were not altered in a sample of older adults with type 2 diabetes in England.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 3, p. 546, doi. 10.1111/dom.14585
- By:
- Publication type:
- Article
Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan‐O randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 1, p. 34, doi. 10.1111/dom.14543
- By:
- Publication type:
- Article
Ethnic, social and multimorbidity disparities in therapeutic inertia: A UK primary care observational study in patients newly diagnosed with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 11, p. 2437, doi. 10.1111/dom.14482
- By:
- Publication type:
- Article
Cardiovascular effects of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: The P value and beyond.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1685, doi. 10.1111/dom.14384
- By:
- Publication type:
- Article
Effects of liraglutide versus sitagliptin on circulating cardiovascular biomarkers, including circulating progenitor cells, in individuals with type 2 diabetes and obesity: Analyses from the LYDIA trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1409, doi. 10.1111/dom.14343
- By:
- Publication type:
- Article
Rates and estimated cost of primary care consultations in people diagnosed with type 2 diabetes and comorbidities: A retrospective analysis of 8.9 million consultations.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1301, doi. 10.1111/dom.14340
- By:
- Publication type:
- Article
Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 425, doi. 10.1111/dom.14234
- By:
- Publication type:
- Article
Cardiovascular events and mortality in people with type 2 diabetes and multimorbidity: A real‐world study of patients followed for up to 19 years.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 218, doi. 10.1111/dom.14218
- By:
- Publication type:
- Article
Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2417, doi. 10.1111/dom.14169
- By:
- Publication type:
- Article
Body mass index and the risk of COVID‐19 across ethnic groups: Analysis of UK Biobank.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1953, doi. 10.1111/dom.14125
- By:
- Publication type:
- Article
Prevalence of co‐morbidities and their association with mortality in patients with COVID‐19: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1915, doi. 10.1111/dom.14124
- By:
- Publication type:
- Article
Number needed to treat in cardiovascular outcome trials of glucagon‐like peptide‐1 receptor agonists: A systematic review with temporal analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1670, doi. 10.1111/dom.14066
- By:
- Publication type:
- Article
A randomized, open‐label, active comparator trial assessing the effects of 26 weeks of liraglutide or sitagliptin on cardiovascular function in young obese adults with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1187, doi. 10.1111/dom.14023
- By:
- Publication type:
- Article
Efficacy and tolerability of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A systematic review and network meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1035, doi. 10.1111/dom.14008
- By:
- Publication type:
- Article
The present and future scope of real‐world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 21, doi. 10.1111/dom.13929
- By:
- Publication type:
- Article
The present and future scope of real‐world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future?
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, p. 21, doi. 10.1111/dom.13929
- By:
- Publication type:
- Article
Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2315, doi. 10.1111/dom.13816
- By:
- Publication type:
- Article
Incorporating and interpreting regulatory guidance on estimands in diabetes clinical trials: The PIONEER 1 randomized clinical trial as an example.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2203, doi. 10.1111/dom.13804
- By:
- Publication type:
- Article
Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1967, doi. 10.1111/dom.13791
- By:
- Publication type:
- Article
Efficacy of low‐ and very‐low‐energy diets in people with type 2 diabetes mellitus: A systematic review and meta‐analysis of interventional studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1695, doi. 10.1111/dom.13727
- By:
- Publication type:
- Article
Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multisite 12‐month prospective observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1585, doi. 10.1111/dom.13690
- By:
- Publication type:
- Article
A multinational observational study assessing insulin use: Understanding the determinants associated with progression of therapy.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1101, doi. 10.1111/dom.13622
- By:
- Publication type:
- Article
Prevalence and progression of diabetic nephropathy in South Asian, white European and African Caribbean people with type 2 diabetes: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 658, doi. 10.1111/dom.13569
- By:
- Publication type:
- Article
Should sodium‐glucose co‐transporter‐2 inhibitors be considered as first‐line oral therapy for people with type 2 diabetes?
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 207, doi. 10.1111/dom.13518
- By:
- Publication type:
- Article
Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: A systematic review and meta‐analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2169, doi. 10.1111/dom.13348
- By:
- Publication type:
- Article
Comparison of glucose‐lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 985, doi. 10.1111/dom.13185
- By:
- Publication type:
- Article
What have we learnt from “real world” data, observational studies and meta‐analyses.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, p. 47, doi. 10.1111/dom.13178
- By:
- Publication type:
- Article
Impact of baseline glycated haemoglobin, diabetes duration and body mass index on clinical outcomes in the LixiLan-O trial testing a titratable fixed-ratio combination of insulin glargine/lixisenatide ( iGlarLixi) vs insulin glargine and lixisenatide monocomponents
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1798, doi. 10.1111/dom.12980
- By:
- Publication type:
- Article
Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high-risk adults: A randomized crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1732, doi. 10.1111/dom.13016
- By:
- Publication type:
- Article
Comment on: ' Strengths and Limitations of Healthcare Databases in the Evaluation of Hypoglycaemia'.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 10, p. 1495, doi. 10.1111/dom.13014
- By:
- Publication type:
- Article
Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 10, p. 1371, doi. 10.1111/dom.12941
- By:
- Publication type:
- Article
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes ( AWARD-9).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1024, doi. 10.1111/dom.12937
- By:
- Publication type:
- Article
Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 4, p. 524, doi. 10.1111/dom.12849
- By:
- Publication type:
- Article
Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 364, doi. 10.1111/dom.12827
- By:
- Publication type:
- Article
Physical activity and structured exercise in patients with type 2 diabetes mellitus and heart failure.
- Published in:
- Practical Diabetes, 2018, v. 35, n. 4, p. 131, doi. 10.1002/pdi.2180
- By:
- Publication type:
- Article
Real‐world evaluation of the DESMOND type 2 diabetes education and self‐management programme.
- Published in:
- Practical Diabetes, 2018, v. 35, n. 1, p. 19, doi. 10.1002/pdi.2154
- By:
- Publication type:
- Article
Let's Prevent Diabetes: from idea to implementation.
- Published in:
- Practical Diabetes, 2017, v. 34, n. 2, p. 55, doi. 10.1002/pdi.2080
- By:
- Publication type:
- Article
DAWN2 study findings: psychosocial support and structured education need to be more widespread.
- Published in:
- Practical Diabetes, 2013, v. 30, n. 6, p. 239, doi. 10.1002/pdi.1784
- By:
- Publication type:
- Article
Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study.
- Published in:
- Vascular Health & Risk Management, 2010, v. 6, p. 837
- By:
- Publication type:
- Article
Associations Between Sedentary Behaviors and Cognitive Function: Cross-Sectional and Prospective Findings From the UK Biobank.
- Published in:
- American Journal of Epidemiology, 2018, v. 187, n. 3, p. 441, doi. 10.1093/aje/kwx273
- By:
- Publication type:
- Article
Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Zinc-alpha2-glycoprotein, dysglycaemia and insulin resistance: a systematic review and meta-analysis.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2020, v. 21, n. 4, p. 569, doi. 10.1007/s11154-020-09553-w
- By:
- Publication type:
- Article